Grantham, Mayo, Van Otterloo & Co (GMO)’s Vertiv VRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.69M Buy
+6,748
New +$1.5M ﹤0.01% 448
2021
Q2
Sell
-45,399
Closed -$908K 855
2021
Q1
$908K Buy
+45,399
New +$917K 0.01% 607

Other funds holding VRT

Grantham, Mayo, Van Otterloo & Co (GMO)'s VRT Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Vertiv (VRT) in Q1 2026: 6,748 shares worth $1.69M. The stake represents ﹤0.01% of the portfolio and ranks #448 among its holdings. This is a return to the name: Grantham, Mayo, Van Otterloo & Co (GMO) previously reported a position in VRT as recently as Q1 2021.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VRT in Q1 2021 and has held it in 2 quarters since. 1,824 funds tracked by Wall St. Rank hold VRT as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 6,748 shares of Vertiv worth $1.69M as of Q1 2026.
  • Vertiv was a new Grantham, Mayo, Van Otterloo & Co (GMO) position in Q1 2026.
  • Vertiv made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #448 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Vertiv in Q1 2021 and has held it in 2 quarters since.
  • 1,824 funds tracked by Wall St. Rank held Vertiv as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.